Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY12 | Q9H244 | 16/20 | 0.59 |
| ▸ | HTR6 | P50406 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | TMIGD3 | P0DMS9 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | CYP8B1 | Q9UNU6 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1968237 | 0.93 | P2RY12 (0.69) | P2RY12HTR6MEN1KMT2ACYP8B1 | |
| SCHEMBL1969384 | 0.91 | P2RY12 (0.58) | P2RY12HTR6MEN1KMT2AKDM4E | |
| SCHEMBL1970556 | 0.90 | P2RY12 (0.55) | P2RY12HTR6MEN1KMT2A | |
| SCHEMBL1971071 | 0.89 | P2RY12 (0.54) | P2RY12HTR6MEN1KMT2AKDM4E | |
| SCHEMBL1970557 | 0.87 | P2RY12 (0.54) | P2RY12HTR6MEN1KMT2AKDM4E | |
| SCHEMBL1969034 | 0.87 | P2RY12 (0.54) | P2RY12HTR6MEN1KMT2ACYP8B1 | |
| SCHEMBL1968984 | 0.86 | P2RY12 (0.60) | P2RY12HTR6MEN1KMT2AKDM4E | |
| SCHEMBL1968627 | 0.86 | P2RY12 (0.67) | P2RY12HTR6MEN1KMT2ACYP8B1 | |
| SCHEMBL1970024 | 0.86 | P2RY12 (0.62) | P2RY12HTR6MEN1KMT2AKDM4E | |
| SCHEMBL1974607 | 0.85 | P2RY12 (0.55) | P2RY12HTR6KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010027236-A2 | FUSED HETEROCYCLIC COMPOUND | LG LIFE SCIENCES LTD. (KR) | 2010-03-11 | — | — | WO | disclosed |